Singh, Harjit; Batra, M. S.; Singh, Paramjit, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1984, vol. 23, # 12, p. 1176 - 1180
[EN] 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS<br/>[FR] COMPOSÉS 1H-PYRAZOLO[4,3-D]PYRIMIDINE UTILES EN TANT QU'AGONISTES DU RÉCEPTEUR DE TYPE TOLL 7 (TLR7)
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2021154665A1
公开(公告)日:2021-08-05
Compounds according to formula I are useful as agonists of Toll-like receptor 7 (TLR7). Such compounds can be used in cancer treatment, especially in combination with an anti-cancer immunotherapy agent, or as a vaccine adjuvant.
N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
申请人:Chen Zhaogen
公开号:US20060009511A9
公开(公告)日:2006-01-12
The present invention provides compounds of formula (I), which are antagonists of the 5-HT
6
receptor.
本发明提供了式(I)的化合物,它们是5-HT6受体的拮抗剂。
N-(2-ARYLETHYL)BENZYLAMINES AS ANTAGONISTS OF THE 5-HT6 RECEPTOR
申请人:Chen Zhaogen
公开号:US20070099909A1
公开(公告)日:2007-05-03
The present invention provides compounds of formula (I), which are antagonists of the 5-HT
6
receptor.
本发明提供了公式(I)的化合物,它们是5-HT6受体的拮抗剂。
N-(2-Arylethyl) benzylamines as antagonists of the 5-HT6 receptor
申请人:Eli Lilly and Company
公开号:US07157488B2
公开(公告)日:2007-01-02
The present invention provides compounds of formula I
pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are antagonists of the 5-HT6 receptor. The present invention further provides a method of treating disorders associated with 5-HT6 receptors, including schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders selected from the group consisting of age-related cognitive decline, mild cognitive impairment, and dementia, comprising: administering to a patient in need thereof an effective amount of a compound of formula I.